HUTCHMED (00013): Donvico (TAZVERIK) has been included in the first edition of the National Commercial Health Insurance Innovative Drug Catalog.

date
08:13 08/12/2025
avatar
GMT Eight
Hwang Pharmaceuticals (0013) announced that after the renewal of medical insurance with the National Medical Insurance Administration (National Medical Insurance Bureau) in China, Elunate (ELUNATE), Orpathys (ORPATHYS), and Sulanda (SULANDA) will continue to be included in the new version of the National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug List (National Medical Insurance Drug List) effective from January 1, 2026. In addition, Tazverik (TAZVERIK) has been included in the first edition of the National Commercial Health Insurance Innovative Drug List (referred to as the Commercial Health Insurance Innovation Drug List).
HUTCHMED (00013) announced that following negotiations with the National Medical Insurance Administration of China (National Medical Insurance Bureau), Elunate, Orpathys, and Sulanda will continue to be included in the new version of the National Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance Drug List (National Medical Insurance Drug List) effective from January 1, 2026. In addition, Tazverik has been included in the first edition of the National Commercial Health Insurance Innovative Drug List (referred to as the Commercial Health Insurance Innovative Drug List).